Genetic assessment in primary hyperoxaluria: why it matters
G Mandrile, B Beck, C Acquaviva, G Rumsby… - Pediatric …, 2023 - Springer
Accurate diagnosis of primary hyperoxaluria (PH) has important therapeutic consequences.
Since biochemical assessment can be unreliable, genetic testing is a crucial diagnostic tool …
Since biochemical assessment can be unreliable, genetic testing is a crucial diagnostic tool …
Improving treatment options for primary hyperoxaluria
B Hoppe, C Martin-Higueras - Drugs, 2022 - Springer
The primary hyperoxalurias are three rare inborn errors of the glyoxylate metabolism in the
liver, which lead to massively increased endogenous oxalate production, thus elevating …
liver, which lead to massively increased endogenous oxalate production, thus elevating …
End points for clinical trials in primary hyperoxaluria
DS Milliner, TL McGregor, A Thompson… - Clinical Journal of the …, 2020 - journals.lww.com
Patients with primary hyperoxaluria experience kidney stones from a young age and can
develop progressive oxalate nephropathy. Progression to kidney failure often develops over …
develop progressive oxalate nephropathy. Progression to kidney failure often develops over …
[HTML][HTML] Diagnosis of inherited retinal diseases
J Birtel, IH Yusuf, C Priglinger… - Klinische …, 2021 - thieme-connect.com
Erbliche Netzhauterkrankungen sind eine häufige Ursache für eine schwere
Sehbehinderung oder Erblindung bei Kindern und Erwachsenen im erwerbsfähigen Alter …
Sehbehinderung oder Erblindung bei Kindern und Erwachsenen im erwerbsfähigen Alter …
Primary hyperoxaluria: the pediatric nephrologist's point of view
E Ben-Shalom, SF Garrelfs… - Clinical Kidney …, 2022 - academic.oup.com
The clinical presentation of primary hyperoxaluria in children ranges from mildly
symptomatic nephrocalcinosis to very early onset end-stage kidney failure with systemic …
symptomatic nephrocalcinosis to very early onset end-stage kidney failure with systemic …
Long-term complications of systemic oxalosis in children—a retrospective single-center cohort study
E Ben-Shalom, R Cytter-Kuint, C Rinat… - Pediatric …, 2021 - Springer
Background Systemic oxalosis is a severe complication seen in primary hyperoxaluria type I
patients with kidney failure. Deposition of insoluble calcium oxalate crystals in multiple …
patients with kidney failure. Deposition of insoluble calcium oxalate crystals in multiple …
Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
SA Hulton - Expert Opinion on Orphan Drugs, 2021 - Taylor & Francis
Introduction Primary hyperoxaluria type 1 (PH1) is an inborn error of glyoxylate metabolism
whereby excessive endogenous oxalate production can result in kidney failure, systemic …
whereby excessive endogenous oxalate production can result in kidney failure, systemic …
Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis
Background Infantile oxalosis, the most devastating form of primary hyperoxaluria type 1
(PH1), often leads to end-stage renal disease (ESRD) during the first weeks to months of life …
(PH1), often leads to end-stage renal disease (ESRD) during the first weeks to months of life …
[HTML][HTML] Improved outcome of infantile oxalosis over time in Europe: data from the OxalEurope Registry
LJ Deesker, SF Garrelfs, G Mandrile… - Kidney International …, 2022 - Elsevier
Introduction Infantile oxalosis is the most severe form of primary hyperoxaluria type 1 (PH1),
with onset of end-stage kidney disease (ESKD) during infancy. We aimed to analyze the …
with onset of end-stage kidney disease (ESKD) during infancy. We aimed to analyze the …
Multimodal imaging of severe oxalate retinopathy in a 20-month-old boy
FB Aygün, S Kadayifcilar, S Lotfi Sadigh… - … Surgery, Lasers and …, 2022 - journals.healio.com
Primary hyperoxaluria type 1 (PH1) is a rare disease due to alanine glyoxylate
aminotransferase enzyme deficiency caused by mutations in AGXT gene. Increased oxalate …
aminotransferase enzyme deficiency caused by mutations in AGXT gene. Increased oxalate …